ATI Pathophysiology Final Exam Related

Review ATI Pathophysiology Final Exam related questions and content

A female patient is prescribed medroxyprogesterone acetate (Provera) for dysfunctional uterine bleeding. What should the nurse include in the patient education?

  • A. This medication may cause breakthrough bleeding or spotting.
  • B. This medication may cause weight gain.
  • C. This medication may increase your risk of developing diabetes.
  • D. This medication may increase your risk of breast cancer.
Correct Answer: A

Rationale: The correct answer is A. Medroxyprogesterone acetate (Provera) can cause breakthrough bleeding or spotting, which is a common side effect of this medication. Choices B, C, and D are incorrect because weight gain, increased risk of diabetes, and increased risk of breast cancer are not commonly associated side effects of medroxyprogesterone acetate. Therefore, the nurse should focus on educating the patient about the potential for breakthrough bleeding or spotting.